Mayinglong Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Mayinglong Pharmaceutical Group has a total shareholder equity of CN¥4.0B and total debt of CN¥180.1M, which brings its debt-to-equity ratio to 4.5%. Its total assets and total liabilities are CN¥5.0B and CN¥968.7M respectively. Mayinglong Pharmaceutical Group's EBIT is CN¥452.1M making its interest coverage ratio -5.6. It has cash and short-term investments of CN¥3.0B.
Key information
4.5%
Debt to equity ratio
CN¥180.06m
Debt
Interest coverage ratio | -5.6x |
Cash | CN¥3.03b |
Equity | CN¥4.04b |
Total liabilities | CN¥968.73m |
Total assets | CN¥5.01b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600993's short term assets (CN¥3.9B) exceed its short term liabilities (CN¥704.9M).
Long Term Liabilities: 600993's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥263.8M).
Debt to Equity History and Analysis
Debt Level: 600993 has more cash than its total debt.
Reducing Debt: 600993's debt to equity ratio has increased from 1.2% to 4.5% over the past 5 years.
Debt Coverage: 600993's debt is well covered by operating cash flow (418.9%).
Interest Coverage: 600993 earns more interest than it pays, so coverage of interest payments is not a concern.